Cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: Results of a phase II/III, placebo-controlled, randomised trial

被引：0
|
作者：
Mersiades, Antony
Kirby, Adrienne
Stockler, Martin R.
Tognela, Annette
Olver, Ian N.
Morton, Rachael L.
Haber, Paul
Walsh, Anna
Lee, Yvonne
Abdi, Ehtesham A.
Della-Fiorentina, Stephen
Aghmesheh, Morteza
Fox, Peter
Briscoe, Karen P.
Sanmugarajah, Jasotha
Marx, Gavin M.
Kichenadasse, Ganessan
Wheeler, Helen
Simes, John
Grimison, Peter S.
机构：
[1] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[2] Northern Beaches Hosp, Sydney, NSW, Australia
[3] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[4] Campbelltown Hosp, Campbell Town, Campbelltown, NSW, Australia
[5] Univ Adelaide, Adelaide, SA, Australia
[6] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia
[7] Southern Highlands Canc Ctr, Bowral, NSW, Australia
[8] Wollongong Hosp, Illawarra Canc Care Ctr, Wollongong, NSW, Australia
[9] Orange Hlth Serv, Orange, NSW, Australia
[10] Coffs Harbour Hlth Campus, Coffs Harbour, NSW, Australia
[11] Griffith Univ, Gold Coast Univ Hosp, Sch Med, Southport, Qld, Australia
[12] Sydney Adventist Hosp, Sydney, NSW, Australia
[13] Flinders Med Ctr, Bedford, Australia
[14] Royal North Shore Hosp, Sydney, NSW, Australia
[15] Chris OBrien Lifehouse, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12019
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Saito, H.
    Yoshizawa, H.
    Yoshimori, K.
    Katakami, N.
    Katsumata, N.
    Kawahara, M.
    Eguchi, K.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 1067 - 1073
  • [42] Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial
    Weinstein, C.
    Jordan, K.
    Green, S. A.
    Camacho, E.
    Khanani, S.
    Beckford-Brathwaite, E.
    Vallejos, W.
    Liang, L. W.
    Noga, S. J.
    Rapoport, B. L.
    ANNALS OF ONCOLOGY, 2016, 27 (01) : 172 - 178
  • [43] A MULTI-INSTITUTIONAL PHASE-III STUDY OF NABILONE VS PLACEBO IN CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    JONES, SE
    DURANT, JR
    GRECO, FA
    ROBERTONE, A
    CANCER TREATMENT REVIEWS, 1982, 9 : 45 - 48
  • [44] PHASE-I/II TRIAL OF GRANISETRON - A NOVEL 5-HYDROXYTRYPTAMINE ANTAGONIST FOR THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
    ADDELMAN, M
    ERLICHMAN, C
    FINE, S
    WARR, D
    MURRAY, C
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (02) : 337 - 341
  • [45] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
    Rozzi, Antonio
    Nardoni, Chiara
    Corona, Michela
    Restuccia, Maria Rosa
    Fabi, Alessandra
    Bria, Emilio
    Minniti, Giuseppe
    Lanzetta, Gaetano
    SUPPORTIVE CARE IN CANCER, 2011, 19 (05) : 697 - 701
  • [46] Supplemental prophylactic intervention for chemotherapy-induced nausea and emesis (SPICE) trial: Protocol for a multicentre double-blind placebo-controlled randomised trial
    Marx, Wolfgang
    McCarthy, Alexandra
    Marshall, Skye
    Crichton, Megan
    Molassiotis, Alex
    Ried, Karin
    Bird, Robert
    Lohning, Anna
    Isenring, Elizabeth
    NUTRITION & DIETETICS, 2020, 77 (01) : 144 - 150
  • [47] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: a phase II study
    Antonio Rozzi
    Chiara Nardoni
    Michela Corona
    Maria Rosa Restuccia
    Alessandra Fabi
    Emilio Bria
    Giuseppe Minniti
    Gaetano Lanzetta
    Supportive Care in Cancer, 2011, 19 : 697 - 701
  • [48] Phase II study of pregabalin for the prevention of chemotherapy induced nausea and vomiting
    Rossi, C. S.
    Cruz, F. M.
    del Giglio, A.
    Rodrigues, C. M.
    Castro, S. N.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] Phase II study of pregabalin for the prevention of chemotherapy induced nausea and vomiting
    Paniquar, Carla Santos Rossi
    del Giglio, Auro
    Yamada, Alayne Magalhaes Trindade Domingues
    Cruz, Felipe Jose Silva Melo
    MUNDO DA SAUDE, 2024, 48
  • [50] Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children
    Parker, RI
    Prakash, D
    Mahan, RA
    Giugliano, DM
    Atlas, MP
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (09) : 578 - 581
12345